Long-term results of prolonged therapy for recurrent genital herpes

Relevance of the problem is the following: recurrent genital herpes and excess body weight share common links in the body’s immune regulation mechanism. It is possible that genital herpes alters the state of the immune system, while excess body weight perpetuates the resulting imbalance. The purpose of this study is to analyze the long-term results of prolonged therapy for recurrent genital herpes in men. As for the methods we should mention that the patients included in the study were divided into two groups: the first group (n=77) consisted of men with recurrent genital herpes and overweight, while the second group (n=64) consisted of men with recurrent genital herpes and normal body weight. Men in both groups received antiviral therapy with valacyclovir at a dose of 500 mg per day for one year. The checkpoints were the following: before the start of therapy, one year after the end of therapy, and two years after the end of therapy. The frequency of relapses and the patients’ subjective experiences were assessed. The results of clinical observations conducted over a two-year period demonstrated the high safety and efficacy of long-term etiological therapy in men with recurrent genital herpes.

Authors

Institutions

Publication Details

Journal
Journal of Adaptive Medical Immunology and Public Health Issues
Published
2026-10-26
DOI
https://doi.org/10.17116/immunology2026202-3126
Primary Topic
Herpesvirus Infections and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Long-term results of prolonged therapy for recurrent genital herpes

Oleg R. Ziganshin, Olga А. Dolnikova, Olga I. Letyaeva
Journal of Adaptive Medical Immunology and Public Health Issues
Herpesvirus Infections and Treatments
article

Long-term results of prolonged therapy for recurrent genital herpes

Oleg R. Ziganshin, Olga А. Dolnikova, Olga I. Letyaeva
article en

Abstract

Relevance of the problem is the following: recurrent genital herpes and excess body weight share common links in the body’s immune regulation mechanism. It is possible that genital herpes alters the state of the immune system, while excess body weight perpetuates the resulting imbalance. The purpose of this study is to analyze the long-term results of prolonged therapy for recurrent genital herpes in men. As for the methods we should mention that the patients included in the study were divided into two groups: the first group (n=77) consisted of men with recurrent genital herpes and overweight, while the second group (n=64) consisted of men with recurrent genital herpes and normal body weight. Men in both groups received antiviral therapy with valacyclovir at a dose of 500 mg per day for one year. The checkpoints were the following: before the start of therapy, one year after the end of therapy, and two years after the end of therapy. The frequency of relapses and the patients’ subjective experiences were assessed. The results of clinical observations conducted over a two-year period demonstrated the high safety and efficacy of long-term etiological therapy in men with recurrent genital herpes.

Journal of Adaptive Medical Immunology and Public Health IssuesVol. 2(2-3)
Chelyabinsk State Medical Academy (RU), Ural State Medical University (RU)
Openalex Percentile: Top 12%
Herpesvirus Infections and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Long-term results of prolonged therapy for recurrent genital herpes — Oleg R. Ziganshin, Olga А. Dolnikova, et al. · Journal of Adaptive Medical Immunology and Public Health Issues (2026) | TGRS Research Map | TGRS